| Literature DB >> 25707768 |
Sheng-Da Hsu, Hsi-Yuan Huang, Chih-Hung Chou, Yi-Ming Sun, Ming-Ta Hsu, Ann-Ping Tsou.
Abstract
BACKGROUND: MicroRNAs (miRNAs) simultaneously target many transcripts through partial complementarity binding, and have emerged as a key type of post-transcriptional regulator for gene expression. How miRNA accomplishes its pleiotropic effects largely depends on its expression and its target repertoire. Previous studies discovered thousands of miRNAs and numerous miRNA target genes mainly through computation and prediction methods which produced high rates of false positive prediction. The development of Argonaute cross-linked immunoprecipitation coupled with high-throughput sequencing (CLIP-Seq) provides a system to effectively determine miRNA target genes. Likewise, the accuracy of dissecting the transcriptional regulation of miRNA genes has been greatly improved by chromatin immunoprecipitation of the transcription factors coupled with sequencing (ChIP-Seq). Elucidation of the miRNA target repertoire will provide an in-depth understanding of the functional roles of microRNA pathways. To reliably reconstruct a miRNA-mediated regulatory network, we established a computational framework using publicly available, sequence-based transcription factor-miRNA databases, including ChIPBase and TransmiR for the TF-miRNA interactions, along with miRNA-target databases, including miRTarBase, TarBase and starBase, for the miRNA-target interactions. We applied the computational framework to elucidate the miRNA-mediated regulatory network in the Mir122a⁻/⁻ mouse model, which has an altered transcriptome and progressive liver disease.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25707768 PMCID: PMC4331712 DOI: 10.1186/1471-2164-16-S2-S12
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Figure 1Overview of the computational framework for reconstructing the miRNA-mediated regulatory network.
List of differentially expressed miRNAs common to both OpenArray analysis and miRNA-Seq.
| Category | miRNA | miRNA loci | miRNA-Seq | OpenArray |
|---|---|---|---|---|
| miR-429-3p | chr4:156053905-156053987:- | 2.01 | 3.56E+00 | |
| miR-200a-3p | chr4:156054896-156054985:- | 2.50 | 2.25E+00 | |
| miR-200b-3p | chr4:156055681-156055750:- | 3.53 | 4.25E+00 | |
| miR-200c-3p | chr6:124718322-124718390:- | 1.86 | 2.88E+00 | |
| miR-182-5p | chr6:30165918-30165992:- | 2.12 | 2.41E+00 | |
| miR-326-3p | chr7:99552269-99552363:+ | 2.07 | 1.83E+00 | |
| miR-199a-5p | chr9:21496495-21496564:- | 3.39 | 1.10E+01 | |
| miR-673-3p | chr12: 109571990-109572080:+ | 34.09 | 3.55E+04 | |
| miR-337-3p | chr12: 109585789-109585885:+ | 22.14 | 9.67E+00 | |
| miR-337-5p | chr12: 109585789-109585885:+ | 59.88 | 2.20E+01 | |
| miR-540-3p | chr12: 109586080-109586146:+ | 26.89 | 1.04E+04 | |
| miR-431-5p | chr12: 109590447-109590537:+ | 34.02 | 5.96E+05 | |
| miR-127-3p | chr12: 109592846-109592915:+ | 61.60 | 1.59E+01 | |
| miR-127-5p | chr12: 109592846-109592915:+ | 38.92 | 3.07E+01 | |
| miR-434-3p | chr12: 109594506-109594599:+ | 68.55 | 2.98E+01 | |
| miR-434-5p | chr12: 109594506-109594599:+ | 49.12 | 2.35E+01 | |
| miR-136-3p | chr12:109595327-109595388:+ | 55.82 | 1.29E+01 | |
| miR-136-5p | chr12:109595327-109595388:+ | 42.94 | 2.49E+00 | |
| miR-379-5p | chr12:109709060-109709125:+ | 46.48 | 1.74E+01 | |
| miR-379-3p | chr12:109709060-109709125:+ | 62.39 | 7.18E+00 | |
| miR-411-3p | chr12:109710175-109710256:+ | 64.08 | 1.16E+01 | |
| miR-411-5p | chr12:109710175-109710256:+ | 56.88 | 2.51E+01 | |
| Up-regulated | miR-299a-5p | chr12:109710638-109710700:+ | 34.89 | 6.81E+02 |
| miR-329-3p | chr12:109713481-109713577:+ | 19.84 | 1.05E+04 | |
| miR-494-3p | chr12:109715318-109715402:+ | 16.36 | 1.35E+03 | |
| miR-1193-3p | chr12:109715671-109715791:+ | 33.38 | 1.07E+01 | |
| miR-543-3p | chr12:109717258-109717333:+ | 28.07 | 5.30E+00 | |
| miR-495-3p | chr12:109718754-109718816:+ | 31.35 | 2.03E+01 | |
| miR-376c-3p | chr12:109722718-109722803:+ | 43.62 | 1.85E+01 | |
| miR-376b-3p | chr12:109723458-109723539:+ | 64.47 | 4.21E+01 | |
| miR-376b-5p | chr12:109723458-109723539:+ | 56.26 | 2.81E+01 | |
| miR-376a-3p | chr12:109723781-109723848:+ | 12.12 | 2.07E+04 | |
| miR-300-3p | chr12:109724313-109724391:+ | 48.31 | 2.87E+03 | |
| miR-381-3p | chr12:109726822-109726896:+ | 59.30 | 2.33E+03 | |
| miR-382-5p | chr12:109733771-109733846:+ | 26.07 | 4.62E+00 | |
| miR-382-3p | chr12:109733771-109733846:+ | 16.26 | 4.37E+03 | |
| miR-134-5p | chr12:109734139-109734209:+ | 41.55 | 3.29E+01 | |
| miR-485-5p | chr12:109734902-109734974:+ | 10.71 | 1.18E+05 | |
| miR-485-3p | chr12:109734902-109734974:+ | 63.49 | 9.91E+01 | |
| miR-154-3p | chr12:109738433-109738498:+ | 63.36 | 8.38E+01 | |
| miR-154-5p | chr12:109738433-109738498:+ | 57.20 | 4.12E+03 | |
| miR-496a-3p | chr12:109739119-109739197:+ | 48.48 | 5.39E+03 | |
| miR-541-5p | chr12:109742409-109742498:+ | 48.98 | 4.90E+01 | |
| miR-409-5p | chr12:109743158-109743236:+ | 16.22 | 7.26E+03 | |
| miR-409-3p | chr12:109743158-109743236:+ | 58.62 | 2.91E+01 | |
| miR-369-3p | chr12:109743418-109743496:+ | 19.52 | 1.03E+04 | |
| miR-369-5p | chr12:109743418-109743496:+ | 7.92 | 2.19E+03 | |
| miR-410-3p | chr12:109743715-109743795:+ | 51.74 | 9.52E+00 | |
| Down-regulated | miR-455-3p | chr4:63256851-63256932:+ | 0.64 | 4.35E-01 |
| miR-455-5p | chr4:63256851-63256932:+ | 0.66 | 3.85E-01 | |
| miR-31-3p | chr4:88910557-88910662:- | 0.40 | 9.54E-02 | |
| miR-31-5p | chr4:88910557-88910662:- | 0.25 | 8.27E-02 | |
| miR-93-5p | chr5:138165523-138165610:- | 0.58 | 9.70E-04 | |
| miR-339-3p | chr5:139369650-139369745:- | 0.57 | 2.59E-01 | |
| miR-335-5p | chr6:30741299-30741396:+ | 0.41 | 3.99E-01 | |
| miR-486b-5p | chr8: 23142573-23142662:- | 0.50 | 3.09E-01 | |
| miR-144-3p | chr11:78073005-78073070:+ | 0.46 | 1.83E-01 | |
| miR-451a | chr11:78073170-78073241:+ | 0.35 | 7.81E-03 | |
| miR-345-5p | chr12:108836973-108837068:+ | 0.52 | 3.19E-01 | |
| miR-17-5p | chr14:115043671-115043754:+ | 0.55 | 2.16E-07 | |
| miR-19a-3p | chr14:115044000-115044081:+ | 0.35 | 4.21E-01 | |
| miR-484 | chr16:14159626-14159692:+ | 0.59 | 6.05E-01 | |
| miR-802-5p | chr16:93369720-93369816:+ | 0.17 | 7.01E-02 | |
| miR-145a-5p | chr18:61647825-61647894:- | 0.56 | 1.95E-01 | |
| miR-322-5p | chrX:53054255-53054349:- | 0.61 | 4.79E-01 | |
There are 48 up-regulated and 17 down-regulated miRNAs in 2-month-old male Mir122a(KO) and WT mice. The expression ratio between the mir-122and WT (KO/WT) is shown.
Figure 2TF-miRNA regulatory network. A total of 240 TF-miRNA interactions involving 40 TFs and 65 DEmiRs were collected for this network, with transcription factor Spi1 and Ctcf binding directly to the promoters of numerous miRNAs. Most of the UPmiRs (41 miRNAs) regulated by Ctcf and Spi1 are located in Chr12qF1. The octagonal nodes represent the transcription factors (TF) and the V-shaped nodes correspond to the miRNAs, while the nodes marked by the blue border represent the miR-122 targets. The up-regulated miRNAs/TFs are marked in red; down-regulated miRNAs/TFs are marked in green; TFs showing no differential expression are marked in grey.
Statistics for curated miRNA-target interactions.
| miRNA | Number of curated targets | Number of DE miRNA target genes in | |
|---|---|---|---|
| miR-429-3p | 438 | 39 | |
| miR-200a-3p | 394 | 25 | |
| miR-200b-3p | 410 | 25 | |
| miR-200c-3p | 382 | 26 | |
| miR-182-5p | 379 | 18 | |
| miR-326-3p | 175 | 16 | |
| miR-199a-5p | 249 | 24 | |
| miR-673-3p | 0 | 0 | |
| miR-337-3p | 36 | 2 | |
| miR-337-5p | 0 | 0 | |
| miR-540-3p | 0 | 0 | |
| miR-431-5p | 178 | 5 | |
| miR-127-3p | 39 | 1 | |
| miR-127-5p | 1 | 0 | |
| miR-434-3p | 7 | 0 | |
| miR-434-5p | 23 | 2 | |
| miR-136-3p | 0 | 0 | |
| miR-136-5p | 501 | 24 | |
| miR-379-5p | 138 | 6 | |
| miR-379-3p | 0 | 0 | |
| miR-411-3p | 26 | 2 | |
| miR-411-5p | 140 | 15 | |
| miR-299a-5p | 18 | 1 | |
| Up-regulated | miR-329-3p | 329 | 5 |
| miR-494-3p | 427 | 26 | |
| miR-1193-3p | 0 | 0 | |
| miR-543-3p | 480 | 36 | |
| miR-495-3p | 644 | 40 | |
| miR-376c-3p | 337 | 18 | |
| miR-376b-3p | 227 | 10 | |
| miR-376b-5p | 0 | 0 | |
| miR-376a-3p | 11 | 1 | |
| miR-300-3p | 40 | 6 | |
| miR-381-3p | 606 | 45 | |
| miR-382-5p | 296 | 20 | |
| miR-382-3p | 1 | 0 | |
| miR-134-5p | 203 | 14 | |
| miR-485-5p | 140 | 9 | |
| miR-485-3p | 0 | 0 | |
| miR-154-3p | 0 | 0 | |
| miR-154-5p | 226 | 11 | |
| miR-496a-3p | 218 | 13 | |
| miR-541-5p | 298 | 20 | |
| miR-409-5p | 0 | 0 | |
| miR-409-3p | 29 | 2 | |
| miR-369-3p | 0 | 0 | |
| miR-369-5p | 0 | 0 | |
| miR-410-3p | 524 | 29 | |
| Down-regulated | miR-455-3p | 3 | 0 |
| miR-455-5p | 0 | 0 | |
| miR-31-3p | 0 | 0 | |
| miR-31-5p | 334 | 36 | |
| miR-93-5p | 705 | 83 | |
| miR-339-3p | 0 | 0 | |
| miR-335-5p | 223 | 19 | |
| miR-486b-5p | 28 | 2 | |
| miR-144-3p | 709 | 72 | |
| miR-451a | 108 | 31 | |
| miR-345-5p | 18 | 5 | |
| miR-17-5p | 992 | 115 | |
| miR-19a-3p | 602 | 62 | |
| miR-484 | 0 | 0 | |
| miR-802-5p | 0 | 0 | |
| miR-145a-5p | 262 | 26 | |
| miR-322-5p | 817 | 80 | |
| Total | 65 DemiRsa | 4,220b* | 499c,* |
a includes 48 up-regulated miRNAs and 17 down-regulated miRNAs
b includes 460 up-regulated target genes and 263 down-regulated target genes, for a total of 723 genes.
c includes 295 up-regulated genes and 204 down-regulated genes of the 886 differentially-expressed genes found in 2-month old Mir122a-/- mouse livers [32].
* indicates the unique gene count
Figure 3UPmiRs regulatory network. This network involves 536 interactions between 33 UPmiRs and 204 DEGs. Fifteen of the 48 UPmiRs did not have known validated targets (Table 2). The regulator hub-UPmiR is miR-381-3p which has 45 target genes (Table S3.1). Down-regulated Nfib being targeted by 12 UPmiRs (Table S3.2) is the miRNA target hub. The background of hub-miRNAs/genes is marked in purple. The V-shaped nodes correspond to the miRNAs, while the rectangle-shaped nodes are the target genes. The up-regulated miRNAs/genes are marked in red; down-regulated miRNAs/genes are marked in green. Regulatory effects are illustrated as blunt ends (⊥) between miRNAs and genes.
Figure 4DNmiRs regulatory network. This network involves 531 interactions between 11 DNmiRs and 295 DEGs. Six of the 17 DNmiRs did not have known validated targets (Table 2). The regulator hub-DNmiR is miR-17-5p which has 115 target genes (Table S3.1). Up-regulated Trp53inp1 being targeted by 7 DNmiRs (Table S3.2) is the miRNA target hub. The background of hub-miRNAs/genes is marked in purple. The V-shaped nodes correspond to the miRNAs, while the rectangle-shaped nodes are the target genes, the nodes marked by the blue border represent the co-miR-122 targets, and the octagonal nodes represent the transcription factors (TF). The up-regulated miRNAs/genes are marked in red; down-regulated miRNAs/genes are marked in green. Regulatory effects are illustrated as blunt ends (⊥) between miRNAs and genes.
Functional analysis of 204 down-regulated target genes of UPmiRs and 295 up-regulated target genes of DNmiRs in IPA "Diseases and Functions".
| Diseases and Functions | UPmiRs | DNmiRs | ||
|---|---|---|---|---|
| Count | Count | |||
| Lipid Metabolism | 3.85E-06 | 22 | ||
| Cellular Growth and Proliferation | 9.18E-06 | 26 | 5.17E-10 | 77 |
| Connective Tissue Disorders | 1.12E-04 | 11 | ||
| Energy Production | 5.59E-04 | 5 | ||
| Metabolic Disease | 8.11E-04 | 8 | ||
| RNA Post-Transcriptional Modification | 1.10E-03 | 3 | ||
| Nervous System Development and Function | 1.57E-03 | 25 | 5.27E-28 | 61 |
| Tissue Development | 1.60E-03 | 34 | 6.33E-29 | 96 |
| Cell-To-Cell Signaling and Interaction | 1.64E-03 | 12 | 6.33E-29 | 54 |
| Cell Death and Survival | 4.27E-03 | 12 | 4.85E-24 | 105 |
| Cellular Assembly and Organization | 4.68E-03 | 17 | 6.33E-29 | 65 |
| Cellular Movement | 6.92E-03 | 6 | 4.52E-09 | 58 |
| Cell Cycle | 1.06E-02 | 4 | 2.28E-07 | 32 |
| Organismal Survival | 1.82E-11 | 99 | ||
| Total number of UPmiR-targets: 57 | ||||
| Total number of DNmiR-targets: 168 | ||||
Function analysis of 204 down-regulated target genes of UPmiRs and 295 up-regulated target genes of DNmiRs in IPA "Canonical Pathways".
| Ingenuity Canonical Pathways | UPmiRs | DNmiRs | ||
|---|---|---|---|---|
| Count | Count | |||
| Superpathway of Cholesterol Biosynthesis | 8.51E-06 | 5 | ||
| Glycogen Biosynthesis II (from UDP-D-Glucose) | 1.10E-03 | 2 | ||
| Pyrimidine Deoxyribonucleotides De Novo Biosynthesis I | 2.09E-02 | 2 | ||
| Regulation of the Epithelial-Mesenchymal Transition Pathway | 4.57E-02 | 5 | 7.76E-02 | 6 |
| Leukocyte Extravasation Signaling | 5.50E-02 | 5 | 4.17E-03 | 9 |
| Integrin Signaling | 5.50E-02 | 5 | 7.59E-05 | 12 |
| PDGF Signaling | 1.98E-01 | 2 | 2.51E-04 | 7 |
| CXCR4 Signaling | 2.12E-01 | 3 | 3.02E-03 | 8 |
| PAK Signaling | 2.29E-01 | 3 | 2.57E-03 | 6 |
| p53 Signaling | 2.64E-01 | 3 | 4.27E-03 | 6 |
| IGF-1 Signaling | 2.64E-01 | 3 | 2.19E-05 | 9 |
| p70S6K Signaling | 3.54E-01 | 3 | 1.20E-02 | 6 |
| RhoA Signaling | 3.54E-01 | 3 | 2.95E-03 | 7 |
| Axonal Guidance Signaling | 4.68E-01 | 5 | 5.50E-04 | 17 |
| Molecular Mechanisms of Cancer | 5.28E-01 | 4 | 2.14E-03 | 14 |
| NRF2-mediated Oxidative Stress Response | 5.42E-01 | 2 | 1.86E-03 | 9 |
| STAT3 Pathway | 5.42E-01 | 1 | 1.78E-04 | 7 |
| TGF-P Signaling | 5.98E-01 | 1 | 7.08E-05 | 8 |
| Glioma Signaling | 6.35E-01 | 1 | 8.32E-04 | 7 |
| Actin Cytoskeleton Signaling | 6.76E-03 | 9 | ||
| Hepatic Fibrosis/Hepatic Stellate Cell Activation | 2.82E-04 | 11 | ||
| Protein Kinase A Signaling | 9.33E-04 | 15 | ||
| ERK/MAPK Signaling | 8.91E-03 | 8 | ||
| PTEN Signaling | 6.03E-04 | 8 | ||
| NF-κB Signaling | 5.37E-03 | 8 | ||
| Regulation of Actin-based Motility by Rho | 2.45E-03 | 6 | ||
| Cell Cycle: G2/M DNA Damage Checkpoint Regulation | 8.13E-03 | 4 | ||
| Total number of UPmiR-targets: 29 | ||||
| Total number of DNmiR-targets: 76 | ||||
Figure 5The target genes of UPmiRs and DNmiRs display distinct functional enrichment in the category of "Diseases and Functions". The functions of the UPmiR-targets are involved in the lipid metabolism and RNA processing while the DNmiR-targets are related to cell growth, cell cycle, tissue development, cell-to-cell signalling and cell survival. The threshold significance level is set at p < 0.05.
Figure 6The target genes of UPmiRs and DNmiRs display distinct functional enrichment in the category of "Canonical Pathway". The functions of the UPmiR-targets are involved in biosynthesis of macromolecules while the DNmiR-targets participate in various cell signalling pathways for cell adhesion, proliferation, cell transformation and hepatic fibrosis. The threshold significance level is set at p < 0.05.